Effect of exercise therapy, systemic acupuncture and silicon oxide tablets on muscular strength, lymphedema, and quality of life in breast cancer survivors: randomized clinical trial

Author:

Giron Patricia Santolia1,Haddad Cinira Assad Simão1,Rizzi Samantha Karla Lopes de Almeida1,Elias Simone1,Nazário Afonso Celso Pinto1,Facina Gil1

Affiliation:

1. Federal University of São Paulo

Abstract

Abstract Purpose: To compare three distinct rehabilitation treatments (exercise therapy, acupuncture, and silicon oxide tablets (Stiper®) in women undergoing breast cancer surgery, assessing strength, lymphedema, and quality of life. Methods: Seventy-nine women with pain above 3 on the visual analogue pain scale (VAS) and with more than 90 days of surgery. Group I was treated with exercise therapy with a duration of 30 minutes, group II treated with 30 minutes of acupuncture using predefined points and group III treated with the same acupuncture points as group II, however, using the silicon oxide in place of needles. Results: There was an improvement in upper limb muscle strength over time in all groups, except for abduction and internal rotation movements. During treatment, there was no increase in the number of patients with lymphedema and there was no statistical difference between the groups. Regarding the EORTC QLQ-C30 quality of life questionnaire, nine of the fifteen factors analyzed showed significant differences between sessions. The factors that did not have significant differences between the three groups were Social Function, Nausea and Vomiting, Dyspnea, Loss of Appetite, Constipation, and Diarrhea. Conclusion:The rehabilitation of physical dysfunctions in women who survived breast cancer through exercise therapy, acupuncture, and silicon oxide tablets in upper limb muscle strength, lymphedema, and quality of life, proved to be effective, without difference between groups. Clinical Trials registry on 01/11/2016, with number NCT02798263.

Publisher

Research Square Platform LLC

Reference29 articles.

1. -Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. PMID: 30207593.

2. -Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, La Vecchia C. Trends and predictions to 2020 in breast cancer mortality in Europe. Breast. 2017 Dec; 36:89–95. doi: 10.1016/j.breast.2017.06.003. Epub 2017 Oct 4. PMID: 28988610.

3. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel);-Łukasiewicz S;2021 Aug

4. Morbidade de membros superiores e qualidade de vida após a biópsia do linfonodo sentinela para tratamento do câncer de mama;-Velloso MSB;Rev Bras Cancerol,2009

5. Alterações funcionais em mulheres submetidas à cirurgia de mama com linfadenectomia axilar total;-Bregagnol RK;Rev Bras Cancerol,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3